Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
ProShares S&P 500 ex-Financials ETF
SPXN
$79.6M
| $6.47M | ﹤0.01% |
140,000
| – | – |
|
|
P
1177
Everpure Inc
P
$29.9B
| $6.46M | ﹤0.01% |
181,296
-144,800
| -44% | -$5.37M |
|
1178
Advanced Drainage Systems
WMS
$10.9B
| $6.46M | ﹤0.01% |
56,708
+5,532
| +11% | +$675K |
|
1179
Helmerich & Payne
HP
$3.71B
| $6.45M | ﹤0.01% |
153,034
+6,111
| +4% | +$255K |
|
1180
PUT
ChargePoint
CHPT
$161M
| $6.4M | ﹤0.01% |
64,430
+63,430
| +6,343% | +$9.2M |
|
1181
CALL
Teck Resources
TECK
$32.6B
| $6.4M | ﹤0.01% |
+148,600
| New | +$6.16M |
|
1182
Alkermes
ALKS
$8.25B
| $6.4M | ﹤0.01% |
228,388
+23,511
| +11% | +$689K |
|
1183
CALL
Banco Santander
SAN
$210B
| $6.39M | ﹤0.01% |
1,700,000
+700,000
| +70% | +$2.65M |
|
1184
AutoNation
AN
$6.92B
| $6.38M | ﹤0.01% |
42,155
-11,784
| -22% | -$1.88M |
|
1185
Enovis
ENOV
$1.53B
| $6.37M | ﹤0.01% |
120,783
+28,727
| +31% | +$1.67M |
|
|
BPMC
1186
DELISTED
Blueprint Medicines
BPMC
| $6.36M | ﹤0.01% |
126,545
+22,198
| +21% | +$1.19M |
|
1187
Post Holdings
POST
$3.57B
| $6.34M | ﹤0.01% |
73,950
-46,997
| -39% | -$4.1M |
|
1188
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
| $6.34M | ﹤0.01% |
+65,391
| New | +$6.35M |
|
1189
PUT
Synopsys
SNPS
$79.7B
| $6.33M | ﹤0.01% |
13,800
-19,800
| -59% | -$8.86M |
|
1190
Revolution Medicines
RVMD
$44B
| $6.33M | ﹤0.01% |
228,661
+42,336
| +23% | +$1.26M |
|
|
BBBY
1191
PUT
Bed Bath & Beyond
BBBY
$442M
| $6.33M | ﹤0.01% |
+440,000
| New | +$10.8M |
|
1192
EastGroup Properties
EGP
$10.9B
| $6.31M | ﹤0.01% |
37,880
+1,574
| +4% | +$279K |
|
1193
Murphy Oil
MUR
$4.78B
| $6.29M | ﹤0.01% |
138,779
-90,928
| -40% | -$3.96M |
|
1194
Lincoln National
LNC
$8.81B
| $6.29M | ﹤0.01% |
254,896
-677,176
| -73% | -$17.7M |
|
1195
Steven Madden
SHOO
$3.55B
| $6.29M | ﹤0.01% |
198,060
+68,199
| +53% | +$2.27M |
|
1196
Spectrum Brands
SPB
$2.07B
| $6.23M | ﹤0.01% |
79,564
-14,690
| -16% | -$1.16M |
|
1197
CALL
Booking.com
BKNG
$161B
| $6.23M | ﹤0.01% |
50,500
-5,050
| -9% | -$612K |
|
1198
Cable One
CABO
$212M
| $6.22M | ﹤0.01% |
10,105
-115
| -1% | -$75.7K |
|
1199
Portland General Electric
POR
$5.77B
| $6.22M | ﹤0.01% |
153,535
-195,581
| -56% | -$8.87M |
|
1200
DT Midstream
DTM
$13.4B
| $6.21M | ﹤0.01% |
117,302
+58,722
| +100% | +$3.06M |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.